Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naive patients with rheumatoid arthritis

Kim Lauper, Denis Mongin, Florenzo Iannone, Eirik K. Kristianslund, Tore K. Kvien, Dan C. Nordström, Karel Pavelka, Manuel Pombo-Suarez, Ziga Rotar, Maria J. Santos, Catalin Codreanu, Galina Lukina, Sara L. Gale, Markus John, Yves Luder, Delphine S. Courvoisier, Cem Gabay

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalSeminars in Arthritis and Rheumatism
Volume50
Issue number1
Pages (from-to)17-24
Number of pages8
ISSN0049-0172
DOIs
Publication statusPublished - Feb 2020
MoE publication typeA1 Journal article-refereed

Fields of Science

  • 3121 General medicine, internal medicine and other clinical medicine
  • Rheumatoid arthritis
  • Biological therapies
  • DMARDs
  • Tocilizumab
  • TNF inhibitors
  • Epidemiology
  • Monotherapy
  • SURVIVAL
  • MANAGEMENT
  • VALIDATION
  • DISCONTINUATION
  • THERAPY
  • DOUBLE-BLIND
  • REMISSION

Cite this